Cadrenal Therapeutics, Inc. (CVKD) Tops Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Join SI Premium – FREE
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q2 EPS of ($1.14), $0.27 better than the analyst estimate of ($1.41).
For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- RBC Capital Upgrades LTC Properties (LTC) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
